Drug Overdose Prevention Information

Having trouble viewing this email? View it as a Web page.

PDO email header

October 1, 2019

Here are your weekly opioid epidemic updates from the Indiana State Department of Health:

Purdue Pharma Files for Bankruptcy as Part of a $10 Billion Agreement to Settle Opioid Lawsuits

Purdue Pharma, the maker of OxyContin, filed for bankruptcy on Sunday, Sept 15. Through filing bankruptcy, the company has agreed to pay state and local governments to help combat the opioid crisis. It is estimated that the company will provide at least $10 billion to address the crisis. In addition, Purdue Pharma plans to create a new company called NewCo. NewCo will make medicine to help reverse overdoses, as well as continuing to develop low-cost naloxone products. Purdue Pharma admitted no wrongdoing, and several attorneys general say that they will continue pursuing legal action against the company.

Back-To-School Season: An Opportunity to Help Parents and Caregivers Prevent Underage Drinking and Drug Use

In the 2018 National Survey on Drug Use and Health, it was reported that 699,000 adolescents and 1.9 million young adults reported misusing opioids. SAMSHA’s national campaign, “Talk. They Hear You.” encourages parents to talk to their children as young as 9 years old about alcohol and drug use. This campaign also encourages parents to engage frequently in these conversations. SAMSHA has additional resources for talking to children about opioids available here.

Preference for Fentanyl Higher Amount Young, White, Frequent Opioid Users

A new study from Johns Hopkins Bloomberg School of Public Health reports the demographics of fentanyl users. The study collected survey responses from 308 people in Baltimore, Boston, and Providence, Rhode Island. Of the 308 respondents, 27 percent reported preferring opioids with fentanyl. Of that 27 percent, the average age of the respondents was 38 years old and 59 percent identified as non-Hispanic white. The 71 percent of respondents who indicated that they did not prefer opioids containing fentanyl had an average age of 45 years old and only 29 percent identified as non-Hispanic white.

Additionally, those who prefer fentanyl reported using opioids more frequently compared to those who do not prefer fentanyl. Ninety-two percent of those who prefer fentanyl reported daily use of opioids compared to the 76 percent of those who do not prefer fentanyl that reported daily use. Fentanyl has jumped to become the leading factor of opioid-related fatal overdoses (3,105 deaths in 2013 to 20,145 deaths in 2016 nationwide).

New Brief on What People Living with Chronic Pain Want Doctors to Know Released by the American Institutes for Research

The American Institutes for Research published a new short guide based on interviews with patients living with chronic pain from a variety of arthritic conditions, including patients taking opioids and patients who had stopped taking opioids after developing an opioid use disorder (OUD). Overall, patients reported wanting their doctors to take more time to clearly explain pain management plans, including being upfront about the potential risks and benefits, and what would happen if they developed an OUD. Patients want to know their doctor is thinking of them as whole person and considering their overall life goals when planning treatment for chronic pain.  

Follow us! @INDTrauma


Check out our website

world wide web logo
light blue divider


light blue divider

ISDH Webcast: Overdose Data to Action: Grant Overview

October 2, 10:00 a.m. ET
Tune into this webinar to learn more about the activities that the ISDH will implement using Overdose Data to Action grant funding. ISDH will also discuss the recently released Request for Proposal - the Indiana Communities Advancing Recovery Efforts (IN CAREs) ECHO. Register here.

light blue divider

Webinar on Opioid Overdose Prevention on Campus

October 10 at 2:00 p.m. ET
Dr. Lucas G. Hill and Lori K. Holleran Steiker of the University of Texas at Austin will discuss the role of naloxone on campus and the implementation of a proactive overdose prevention model. Additional information and registration available here.

light blue divider

First Responder Resiliency and Peer Support Course

October 21 - October 25
This 40-hour course will allow attendees to learn how to serve as a peer supporter, conduct individual psychological debriefings, and make appropriate referrals for peers and their family members to enhance human resiliency. Audience may include first responders, administrators, police, emergency services personnel, fire fighters, chaplains, probation, parole and dispatchers. Register here

light blue divider

Attorney General's 10th Annual Prescription Drug Abuse Symposium

October 29 - October 30
This program is the largest statewide collaboration of professionals impacted by drug abuse. Through this type of collaboration, your work can be impactful in bringing solutions to this issue as we examine critical and emerging topics associated with this public health and safety crisis. Register here.

light blue divider

Recovery & Culture Training

November 6 - November 8
This 3 day, 18 CEU course provided by the Indiana Addictions Issues Coalition is designed to help recovery professionals be more effective in working with people in recovery from diverse cultures. Additional information and registration available here.

light blue divider